RAPTOR RESOURCES LIMITED - Announcements

0.00%

20.5¢

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

ResApp Health Limited is an Australia-based digital health company engaged in developing... ResApp Health Limited is an Australia-based digital health company engaged in developing smartphone applications for the diagnosis and management of respiratory disease. The Company provides point of care diagnostic solutions for telehealth that are integrated into existing platforms. The Company is focused on developing apps to provide instant clinical diagnostic tests and management tools directly to consumers and healthcare providers. The Company’s machine learning algorithms use sound to diagnose and measure the severity of respiratory conditions without the need for additional accessories or hardware. Its products include ResAppDx, a smartphone-based acute respiratory disease diagnostic test for use in telehealth, emergency department and primary care settings; and SleepCheck, a smartphone application which allows consumers to self-assess their risk of sleep apnoea. Its obstructive sleep aponia screening test uses overnight breathing and snoring sounds recorded on a smartphone.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

RAP	First patients recruited in COVID-19 clinical study in India		20/09/21	110.38KB	Share
RAP	ResApp receives Advanced and Overseas R&D Finding	PRICE SENSITIVE	14/09/21	103.8KB	Share
RAP	ResAppDx receives regulatory approval in Indonesia		01/09/21	98.18KB	Share
RAP	Appendix 4G		27/08/21	283.16KB	Share
RAP	Corporate Governance Statement		27/08/21	139.15KB	Share
RAP	Appendix 4E and Annual Report	PRICE SENSITIVE	27/08/21	6.2MB	Share
RAP	Investor Webinar Presentation		18/08/21	9.06MB	Share
RAP	ResApp expands COVID-19 clinical program		09/08/21	124.08KB	Share
RAP	Alodokter to launch ResAppDx in Indonesia	PRICE SENSITIVE	04/08/21	113.3KB	Share
RAP	Medgate enters licence agreement with ResApp Health	PRICE SENSITIVE	04/08/21	113.2KB	Share
RAP	Trading Halt	PRICE SENSITIVE	02/08/21	226.82KB	Share
RAP	Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	30/07/21	323.96KB	Share
RAP	Quarterly Results and Investor Conference Call Notification		28/07/21	90.68KB	Share
RAP	Commercial agreement with Doctors on Demand in Australia	PRICE SENSITIVE	05/07/21	121.05KB	Share
RAP	ResApp study data published in peer-reviewed journal		05/07/21	106.88KB	Share
RAP	Notification of cessation of securities - RAP		02/07/21	25.94KB	Share
RAP	ResApp to present at the Gold Coast Investment Showcase		23/06/21	90.3KB	Share
RAP	Medgate extends European ResAppDx trial		03/06/21	103.5KB	Share
RAP	Corporate Overview Presentation		20/05/21	8.92MB	Share
RAP	Initial Director's Interest Notice		18/05/21	150.41KB	Share
RAP	Brian Leedman Reappointed as Executive Director		18/05/21	104.63KB	Share
RAP	First participant recruited in COVID-19 cough study		17/05/21	120.95KB	Share
RAP	Agreement with Ilara Health to sell ResAppDx in Kenya	PRICE SENSITIVE	04/05/21	118.61KB	Share
RAP	Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	30/04/21	322.27KB	Share
RAP	Quarterly Results and Investor Conference Call Notification		29/04/21	90.41KB	Share
RAP	Change in substantial holding		21/04/21	188.58KB	Share
RAP	Ceasing to be a substantial holder		20/04/21	355.98KB	Share
RAP	Appendix 3G		19/04/21	286.66KB	Share
RAP	Section 708A Notice and Appendix 2A		19/04/21	405.89KB	Share
RAP	Proposed issue of Securities - RAP		12/04/21	28.53KB	Share
RAP	ResApp secures firm commitments to raise $5.5 million	PRICE SENSITIVE	12/04/21	125.67KB	Share
RAP	Trading Halt	PRICE SENSITIVE	08/04/21	566.64KB	Share
RAP	Appendix 3G		01/04/21	352.53KB	Share
RAP	TGA clearance achieved for wearable		25/03/21	103.57KB	Share
RAP	Change of Director's Interest Notice - Chris Ntoumenopoulos		16/03/21	204.71KB	Share
RAP	Change of Director's Interest Notice - Tony Keating		16/03/21	210.37KB	Share
RAP	Change of Director's Interest Notice - Roger Aston		16/03/21	202.72KB	Share
RAP	Change in substantial holding		16/03/21	214.87KB	Share
RAP	Change in substantial holding		16/03/21	214.87KB	Share
RAP	Section 708A Notice and Appendix 2A		12/03/21	412.59KB	Share
RAP	S&P DJI Announces March 2021 Quarterly Rebalance	PRICE SENSITIVE	12/03/21	183.24KB	Share
RAP	ResApp grants SDK licence to AstraZeneca for asthma program	PRICE SENSITIVE	12/03/21	117.37KB	Share
RAP	Clinical study to develop COVID-19 screening test	PRICE SENSITIVE	11/03/21	121.12KB	Share
RAP	Medgate commences European ResAppDx trial	PRICE SENSITIVE	04/03/21	104.25KB	Share
RAP	Proposed issue of Securities - RAP		02/03/21	24.57KB	Share
RAP	CE Mark achieved for wearable device	PRICE SENSITIVE	02/03/21	2.35MB	Share
RAP	Update on Licencing Agreement with WMA		26/02/21	94.08KB	Share
RAP	Resignation of Joint Company Secretary		25/02/21	172.2KB	Share
RAP	Appendix 4D and Half Year Financial Report	PRICE SENSITIVE	24/02/21	1.89MB	Share
RAP	Pre-Submission package lodged with the US FDA	PRICE SENSITIVE	10/02/21	99.76KB	Share
RAP	ResApp receives $801,738 R&D tax incentive refund and grant	PRICE SENSITIVE	04/02/21	88.81KB	Share
RAP	ResApp strengthens patent position in Europe		02/02/21	95.56KB	Share
RAP	Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	29/01/21	332.05KB	Share
RAP	Quarterly Results and Investor Conference Call Notification		28/01/21	86.68KB	Share
RAP	Appendix 3G		12/01/21	415.03KB	Share
RAP	ResApp appoints VP, Commercial to progress growth strategy		11/01/21	104.34KB	Share
RAP	SleepCheck Launched on Select Android Devices	PRICE SENSITIVE	29/12/20	108.43KB	Share
RAP	ResApp Terminates MOU with RB		23/12/20	131.16KB	Share
RAP	Software updates for ResAppDx to underpin growth		22/12/20	119.03KB	Share
RAP	S&P DJI Announces December 2020 Quarterly Rebalance	PRICE SENSITIVE	11/12/20	118.95KB	Share
RAP	Appointment of Joint Company Secretary		04/12/20	170.62KB	Share
RAP	Change of Director's Interest Notice		02/12/20	162.37KB	Share
RAP	Appendix 3G		02/12/20	289.62KB	Share
RAP	Notification of Change of Auditor		26/11/20	143.8KB	Share
RAP	Adoption of New Constitution		26/11/20	721.06KB	Share
RAP	Results of Annual General Meeting		26/11/20	307.3KB	Share
RAP	Annual General Meeting Presentation		26/11/20	3.68MB	Share
RAP	2020 Letter to Shareholders		26/11/20	116.49KB	Share
RAP	Positive engagement with US FDA following SleepCheck Pre-Sub		24/11/20	139.94KB	Share
RAP	ResAppDx to be integrated into WMA telehealth application		19/11/20	146.99KB	Share
RAP	Medgate to pilot ResAppDx for telehealth across Europe	PRICE SENSITIVE	09/11/20	112.99KB	Share
RAP	Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	30/10/20	334.04KB	Share
RAP	ResAppDx launched on select Android devices	PRICE SENSITIVE	28/10/20	110.79KB	Share
RAP	Quarterly Results and Investor Conference Call Notification		27/10/20	90.54KB	Share
RAP	Notice of Annual General Meeting/Proxy Form		26/10/20	1.69MB	Share
RAP	AstraZeneca to use new ResApp software in study - Revised	PRICE SENSITIVE	22/10/20	116.6KB	Share
RAP	Pause in Trading	PRICE SENSITIVE	22/10/20	114.77KB	Share
RAP	AstraZeneca to use new ResApp software in clinical study	PRICE SENSITIVE	22/10/20	116.53KB	Share
RAP	Partners with largest Australian consumer healthcare network	PRICE SENSITIVE	21/10/20	137.87KB	Share
RAP	ResApp Partners with Diabetes Queensland for SleepCheck		28/09/20	116.01KB	Share
RAP	Section 708A Notice and Appendix 2A		22/09/20	423.15KB	Share
RAP	SleepCheck Pre-Submission Package Lodged with the US FDA		21/09/20	128.37KB	Share
RAP	Continued Use of ResAppDx at COVID-19 Respiratory Clinic		01/09/20	95.22KB	Share
RAP	Appendix 4G		31/08/20	207.43KB	Share
RAP	Corporate Governance Statement		31/08/20	131.82KB	Share
RAP	Appendix 4E and Annual Report	PRICE SENSITIVE	31/08/20	1.3MB	Share
RAP	SleepCheck Now Available in 36 Countries		04/08/20	97.65KB	Share
RAP	Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	29/07/20	297.01KB	Share
RAP	Quarterly Results and Investor Conference Call Notification		24/07/20	90.58KB	Share
RAP	ResApp to Present at ShareCafe Investor Webinar		17/07/20	8.51MB	Share
RAP	Change of Director's Interest Notice		02/07/20	272.56KB	Share
RAP	Section 708A Notice and Appendix 2A		01/07/20	427.02KB	Share
RAP	ResAppDx-EU to be Launched on Phenix Health Telehealth App		01/07/20	119.68KB	Share
RAP	Coviu and ResApp Health Sign Service Agreement	PRICE SENSITIVE	01/07/20	191.9KB	Share
RAP	Ilara and ResApp Announce Evaluation of ResAppDx in Africa		30/06/20	130.72KB	Share
RAP	SleepCheck App for iPhone Now Available on the App Store	PRICE SENSITIVE	29/06/20	757.94KB	Share
RAP	DARPA WASH Program Update		29/06/20	95.31KB	Share
RAP	ResApp Signs MOU to Develop Respiratory App for Consumers	PRICE SENSITIVE	18/06/20	96.29KB	Share
RAP	Phenix and ResApp Sign Software Licensing Agreement	PRICE SENSITIVE	16/06/20	119.7KB	Share
RAP	S&P DJI Announces June 2020 Quarterly Rebalance	PRICE SENSITIVE	12/06/20	223.16KB	Share

RAP First patients recruited in COVID-19 clinical study in India
20/09/21		110.38KB	Share
RAP ResApp receives Advanced and Overseas R&D Finding
14/09/21	PRICE SENSITIVE	103.8KB	Share
RAP ResAppDx receives regulatory approval in Indonesia
01/09/21		98.18KB	Share
RAP Appendix 4G
27/08/21		283.16KB	Share
RAP Corporate Governance Statement
27/08/21		139.15KB	Share
RAP Appendix 4E and Annual Report
27/08/21	PRICE SENSITIVE	6.2MB	Share
RAP Investor Webinar Presentation
18/08/21		9.06MB	Share
RAP ResApp expands COVID-19 clinical program
09/08/21		124.08KB	Share
RAP Alodokter to launch ResAppDx in Indonesia
04/08/21	PRICE SENSITIVE	113.3KB	Share
RAP Medgate enters licence agreement with ResApp Health
04/08/21	PRICE SENSITIVE	113.2KB	Share
RAP Trading Halt
02/08/21	PRICE SENSITIVE	226.82KB	Share
RAP Quarterly Activities Report and Appendix 4C
30/07/21	PRICE SENSITIVE	323.96KB	Share
RAP Quarterly Results and Investor Conference Call Notification
28/07/21		90.68KB	Share
RAP Commercial agreement with Doctors on Demand in Australia
05/07/21	PRICE SENSITIVE	121.05KB	Share
RAP ResApp study data published in peer-reviewed journal
05/07/21		106.88KB	Share
RAP Notification of cessation of securities - RAP
02/07/21		25.94KB	Share
RAP ResApp to present at the Gold Coast Investment Showcase
23/06/21		90.3KB	Share
RAP Medgate extends European ResAppDx trial
03/06/21		103.5KB	Share
RAP Corporate Overview Presentation
20/05/21		8.92MB	Share
RAP Initial Director's Interest Notice
18/05/21		150.41KB	Share
RAP Brian Leedman Reappointed as Executive Director
18/05/21		104.63KB	Share
RAP First participant recruited in COVID-19 cough study
17/05/21		120.95KB	Share
RAP Agreement with Ilara Health to sell ResAppDx in Kenya
04/05/21	PRICE SENSITIVE	118.61KB	Share
RAP Quarterly Activities Report and Appendix 4C
30/04/21	PRICE SENSITIVE	322.27KB	Share
RAP Quarterly Results and Investor Conference Call Notification
29/04/21		90.41KB	Share
RAP Change in substantial holding
21/04/21		188.58KB	Share
RAP Ceasing to be a substantial holder
20/04/21		355.98KB	Share
RAP Appendix 3G
19/04/21		286.66KB	Share
RAP Section 708A Notice and Appendix 2A
19/04/21		405.89KB	Share
RAP Proposed issue of Securities - RAP
12/04/21		28.53KB	Share
RAP ResApp secures firm commitments to raise $5.5 million
12/04/21	PRICE SENSITIVE	125.67KB	Share
RAP Trading Halt
08/04/21	PRICE SENSITIVE	566.64KB	Share
RAP Appendix 3G
01/04/21		352.53KB	Share
RAP TGA clearance achieved for wearable
25/03/21		103.57KB	Share
RAP Change of Director's Interest Notice - Chris Ntoumenopoulos
16/03/21		204.71KB	Share
RAP Change of Director's Interest Notice - Tony Keating
16/03/21		210.37KB	Share
RAP Change of Director's Interest Notice - Roger Aston
16/03/21		202.72KB	Share
RAP Change in substantial holding
16/03/21		214.87KB	Share
RAP Change in substantial holding
16/03/21		214.87KB	Share
RAP Section 708A Notice and Appendix 2A
12/03/21		412.59KB	Share
RAP S&P DJI Announces March 2021 Quarterly Rebalance
12/03/21	PRICE SENSITIVE	183.24KB	Share
RAP ResApp grants SDK licence to AstraZeneca for asthma program
12/03/21	PRICE SENSITIVE	117.37KB	Share
RAP Clinical study to develop COVID-19 screening test
11/03/21	PRICE SENSITIVE	121.12KB	Share
RAP Medgate commences European ResAppDx trial
04/03/21	PRICE SENSITIVE	104.25KB	Share
RAP Proposed issue of Securities - RAP
02/03/21		24.57KB	Share
RAP CE Mark achieved for wearable device
02/03/21	PRICE SENSITIVE	2.35MB	Share
RAP Update on Licencing Agreement with WMA
26/02/21		94.08KB	Share
RAP Resignation of Joint Company Secretary
25/02/21		172.2KB	Share
RAP Appendix 4D and Half Year Financial Report
24/02/21	PRICE SENSITIVE	1.89MB	Share
RAP Pre-Submission package lodged with the US FDA
10/02/21	PRICE SENSITIVE	99.76KB	Share
RAP ResApp receives $801,738 R&D tax incentive refund and grant
04/02/21	PRICE SENSITIVE	88.81KB	Share
RAP ResApp strengthens patent position in Europe
02/02/21		95.56KB	Share
RAP Quarterly Activities Report and Appendix 4C
29/01/21	PRICE SENSITIVE	332.05KB	Share
RAP Quarterly Results and Investor Conference Call Notification
28/01/21		86.68KB	Share
RAP Appendix 3G
12/01/21		415.03KB	Share
RAP ResApp appoints VP, Commercial to progress growth strategy
11/01/21		104.34KB	Share
RAP SleepCheck Launched on Select Android Devices
29/12/20	PRICE SENSITIVE	108.43KB	Share
RAP ResApp Terminates MOU with RB
23/12/20		131.16KB	Share
RAP Software updates for ResAppDx to underpin growth
22/12/20		119.03KB	Share
RAP S&P DJI Announces December 2020 Quarterly Rebalance
11/12/20	PRICE SENSITIVE	118.95KB	Share
RAP Appointment of Joint Company Secretary
04/12/20		170.62KB	Share
RAP Change of Director's Interest Notice
02/12/20		162.37KB	Share
RAP Appendix 3G
02/12/20		289.62KB	Share
RAP Notification of Change of Auditor
26/11/20		143.8KB	Share
RAP Adoption of New Constitution
26/11/20		721.06KB	Share
RAP Results of Annual General Meeting
26/11/20		307.3KB	Share
RAP Annual General Meeting Presentation
26/11/20		3.68MB	Share
RAP 2020 Letter to Shareholders
26/11/20		116.49KB	Share
RAP Positive engagement with US FDA following SleepCheck Pre-Sub
24/11/20		139.94KB	Share
RAP ResAppDx to be integrated into WMA telehealth application
19/11/20		146.99KB	Share
RAP Medgate to pilot ResAppDx for telehealth across Europe
09/11/20	PRICE SENSITIVE	112.99KB	Share
RAP Quarterly Activities Report and Appendix 4C
30/10/20	PRICE SENSITIVE	334.04KB	Share
RAP ResAppDx launched on select Android devices
28/10/20	PRICE SENSITIVE	110.79KB	Share
RAP Quarterly Results and Investor Conference Call Notification
27/10/20		90.54KB	Share
RAP Notice of Annual General Meeting/Proxy Form
26/10/20		1.69MB	Share
RAP AstraZeneca to use new ResApp software in study - Revised
22/10/20	PRICE SENSITIVE	116.6KB	Share
RAP Pause in Trading
22/10/20	PRICE SENSITIVE	114.77KB	Share
RAP AstraZeneca to use new ResApp software in clinical study
22/10/20	PRICE SENSITIVE	116.53KB	Share
RAP Partners with largest Australian consumer healthcare network
21/10/20	PRICE SENSITIVE	137.87KB	Share
RAP ResApp Partners with Diabetes Queensland for SleepCheck
28/09/20		116.01KB	Share
RAP Section 708A Notice and Appendix 2A
22/09/20		423.15KB	Share
RAP SleepCheck Pre-Submission Package Lodged with the US FDA
21/09/20		128.37KB	Share
RAP Continued Use of ResAppDx at COVID-19 Respiratory Clinic
01/09/20		95.22KB	Share
RAP Appendix 4G
31/08/20		207.43KB	Share
RAP Corporate Governance Statement
31/08/20		131.82KB	Share
RAP Appendix 4E and Annual Report
31/08/20	PRICE SENSITIVE	1.3MB	Share
RAP SleepCheck Now Available in 36 Countries
04/08/20		97.65KB	Share
RAP Quarterly Activities Report and Appendix 4C
29/07/20	PRICE SENSITIVE	297.01KB	Share
RAP Quarterly Results and Investor Conference Call Notification
24/07/20		90.58KB	Share
RAP ResApp to Present at ShareCafe Investor Webinar
17/07/20		8.51MB	Share
RAP Change of Director's Interest Notice
02/07/20		272.56KB	Share
RAP Section 708A Notice and Appendix 2A
01/07/20		427.02KB	Share
RAP ResAppDx-EU to be Launched on Phenix Health Telehealth App
01/07/20		119.68KB	Share
RAP Coviu and ResApp Health Sign Service Agreement
01/07/20	PRICE SENSITIVE	191.9KB	Share
RAP Ilara and ResApp Announce Evaluation of ResAppDx in Africa
30/06/20		130.72KB	Share
RAP SleepCheck App for iPhone Now Available on the App Store
29/06/20	PRICE SENSITIVE	757.94KB	Share
RAP DARPA WASH Program Update
29/06/20		95.31KB	Share
RAP ResApp Signs MOU to Develop Respiratory App for Consumers
18/06/20	PRICE SENSITIVE	96.29KB	Share
RAP Phenix and ResApp Sign Software Licensing Agreement
16/06/20	PRICE SENSITIVE	119.7KB	Share
RAP S&P DJI Announces June 2020 Quarterly Rebalance
12/06/20	PRICE SENSITIVE	223.16KB	Share

REFRESH

First 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

RAPTOR RESOURCES LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Top Stories

Corporate Spotlight
Not Yet Available